A new botanical drug, HL tablet, reduces significantly hepatic fat by MR spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase LL clinical trial

Authors
Category Primary study
JournalHepatology
Year 2015
This article has no abstract
Epistemonikos ID: b65cc8012458a788e36b529ee00e3fc7ec12c971
First added on: Feb 08, 2025